AGL 40.10 Increased By ▲ 0.10 (0.25%)
AIRLINK 131.50 Increased By ▲ 1.97 (1.52%)
BOP 6.85 Increased By ▲ 0.17 (2.54%)
CNERGY 4.63 No Change ▼ 0.00 (0%)
DCL 9.07 Increased By ▲ 0.13 (1.45%)
DFML 43.67 Increased By ▲ 1.98 (4.75%)
DGKC 84.20 Increased By ▲ 0.43 (0.51%)
FCCL 33.05 Increased By ▲ 0.28 (0.85%)
FFBL 78.25 Increased By ▲ 2.78 (3.68%)
FFL 11.50 Increased By ▲ 0.03 (0.26%)
HUBC 110.51 Decreased By ▼ -0.04 (-0.04%)
HUMNL 14.72 Increased By ▲ 0.16 (1.1%)
KEL 5.40 Increased By ▲ 0.01 (0.19%)
KOSM 8.30 Decreased By ▼ -0.10 (-1.19%)
MLCF 39.84 Increased By ▲ 0.05 (0.13%)
NBP 61.00 Increased By ▲ 0.71 (1.18%)
OGDC 202.25 Increased By ▲ 2.59 (1.3%)
PAEL 26.75 Increased By ▲ 0.10 (0.38%)
PIBTL 7.93 Increased By ▲ 0.27 (3.52%)
PPL 161.67 Increased By ▲ 3.75 (2.37%)
PRL 26.60 Decreased By ▼ -0.13 (-0.49%)
PTC 18.57 Increased By ▲ 0.11 (0.6%)
SEARL 82.23 Decreased By ▼ -0.21 (-0.25%)
TELE 8.27 Decreased By ▼ -0.04 (-0.48%)
TOMCL 34.48 Decreased By ▼ -0.03 (-0.09%)
TPLP 9.17 Increased By ▲ 0.11 (1.21%)
TREET 17.21 Decreased By ▼ -0.26 (-1.49%)
TRG 61.40 Increased By ▲ 0.08 (0.13%)
UNITY 27.70 Increased By ▲ 0.27 (0.98%)
WTL 1.42 Increased By ▲ 0.04 (2.9%)
BR100 10,557 Increased By 150 (1.44%)
BR30 32,067 Increased By 353.6 (1.11%)
KSE100 98,306 Increased By 977.3 (1%)
KSE30 30,558 Increased By 365.3 (1.21%)

Pfizer voiced hope Thursday it could roll out up to 20 million doses of a COVID-19 vaccine it is developing with German firm Biontech for emergency use by the end of 2020Pfizer.

The two companies are working on four possible vaccines against the new coronavirus, and launched clinical trials using volunteers in Germany earlier this month.

The head of the US pharma giant's vaccines unit, Nanette Cocero, told a virtual briefing Thursday that the companies were moving forward to ramp up clinical trials and manufacturing capabilities in parallel to be able to produce a large number of doses as soon as a vaccine is demonstrated to be safe and efficient.

It can take years for a new vaccine to be licensed for general use, but in the face of the COVID-19 pandemic, experimental vaccines shown to be safe and effective against the novel coronavirus could likely win approval for emergency use. The virus, which first surfaced in China late last year, has killed nearly 230,000 people and infected close to 3.2 million worldwide, according to a tally from official sources compiled by AFP.

Copyright Agence France-Presse, 2020

Comments

Comments are closed.